JP2019529501A - 可逆的に保護された、チオレート化求電子性脂肪酸としてのプロドラッグ - Google Patents

可逆的に保護された、チオレート化求電子性脂肪酸としてのプロドラッグ Download PDF

Info

Publication number
JP2019529501A
JP2019529501A JP2019517823A JP2019517823A JP2019529501A JP 2019529501 A JP2019529501 A JP 2019529501A JP 2019517823 A JP2019517823 A JP 2019517823A JP 2019517823 A JP2019517823 A JP 2019517823A JP 2019529501 A JP2019529501 A JP 2019529501A
Authority
JP
Japan
Prior art keywords
acid
fatty acid
thiolated
carbon
disease
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2019517823A
Other languages
English (en)
Japanese (ja)
Other versions
JP2019529501A5 (enExample
Inventor
ブルース エー フリーマン
ブルース エー フリーマン
ニコラス クー
ニコラス クー
フランシスコ ジェイ ショップファー
フランシスコ ジェイ ショップファー
スティーブン ウッドコック
スティーブン ウッドコック
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
University of Pittsburgh
Original Assignee
University of Pittsburgh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by University of Pittsburgh filed Critical University of Pittsburgh
Publication of JP2019529501A publication Critical patent/JP2019529501A/ja
Publication of JP2019529501A5 publication Critical patent/JP2019529501A5/ja
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C205/00—Compounds containing nitro groups bound to a carbon skeleton
    • C07C205/01—Compounds containing nitro groups bound to a carbon skeleton having nitro groups bound to acyclic carbon atoms
    • C07C205/03—Compounds containing nitro groups bound to a carbon skeleton having nitro groups bound to acyclic carbon atoms of an unsaturated carbon skeleton

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Diabetes (AREA)
  • Child & Adolescent Psychology (AREA)
  • Urology & Nephrology (AREA)
  • Epidemiology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
JP2019517823A 2016-10-05 2017-10-04 可逆的に保護された、チオレート化求電子性脂肪酸としてのプロドラッグ Pending JP2019529501A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201662404368P 2016-10-05 2016-10-05
US62/404,368 2016-10-05
PCT/US2017/055149 WO2018067705A1 (en) 2016-10-05 2017-10-04 Reversibly protected thiolated electrophilic fatty acids as prodrugs

Publications (2)

Publication Number Publication Date
JP2019529501A true JP2019529501A (ja) 2019-10-17
JP2019529501A5 JP2019529501A5 (enExample) 2020-11-12

Family

ID=61832194

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2019517823A Pending JP2019529501A (ja) 2016-10-05 2017-10-04 可逆的に保護された、チオレート化求電子性脂肪酸としてのプロドラッグ

Country Status (7)

Country Link
US (3) US10744106B2 (enExample)
EP (1) EP3522884B1 (enExample)
JP (1) JP2019529501A (enExample)
CN (1) CN109803648A (enExample)
CA (1) CA3039376A1 (enExample)
ES (1) ES2982757T3 (enExample)
WO (1) WO2018067705A1 (enExample)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2019529517A (ja) 2016-10-05 2019-10-17 ユニバーシティ オブ ピッツバーグ − オブ ザ コモンウェルス システム オブ ハイヤー エデュケイション ニトロソ化およびアルキル化反応を媒介するニトロアルケンの新規可逆的窒素酸化物誘導体
WO2020102529A1 (en) 2018-11-14 2020-05-22 University Of Pittsburgh - Of The Commonwealth System Of Higher Education Electrophiles and electrophile pro-drugs as rad51 inhibitors
WO2021242758A1 (en) * 2020-05-26 2021-12-02 Imara Inc. Improved nitro-fatty acid oral dose regimens
CN118845745B (zh) * 2024-09-25 2024-12-17 浙江大学医学院附属第二医院 辛酸钠在制备治疗脓毒症药物中的应用

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8324277B2 (en) 2007-08-01 2012-12-04 University of Pittsburgh—of the Commonwealth System of Higher Education Nitrated-fatty acids modulation of type II diabetes
WO2010014889A2 (en) 2008-08-01 2010-02-04 University Of Pittsburgh-Of The Commonwealth System Of Higher Education Nitro fatty acids as regiomers and related mimetics
JP2013500966A (ja) 2009-07-31 2013-01-10 ユニバーシティー オブ ピッツバーグ − オブ ザ コモンウェルス システム オブ ハイヤー エデュケーション 抗炎症剤としての脂肪酸
US20150018417A1 (en) 2012-02-03 2015-01-15 University Of Pittsburgh - Of The Commonwealth System Of Higher Education Fatty acids as anti-inflammatory agents
JP6959246B2 (ja) 2016-03-04 2021-11-02 ユニバーシティ オブ ピッツバーグ−オブ ザ コモンウェルス システム オブ ハイヤー エデュケーションＵｎｉｖｅｒｓｉｔｙ Ｏｆ Ｐｉｔｔｓｂｕｒｇｈ Ｏｆ Ｔｈｅ Ｃｏｍｍｏｎｗｅａｌｔｈ Ｓｙｓｔｅｍ Ｏｆ Ｈｉｇｈｅｒ Ｅｄｕｃａｔｉｏｎ 治療に有効な量のジカルボン酸化合物を使用した、病気の予防、治療及び治癒
JP2019529517A (ja) 2016-10-05 2019-10-17 ユニバーシティ オブ ピッツバーグ − オブ ザ コモンウェルス システム オブ ハイヤー エデュケイション ニトロソ化およびアルキル化反応を媒介するニトロアルケンの新規可逆的窒素酸化物誘導体

Also Published As

Publication number Publication date
US20190282527A1 (en) 2019-09-19
US10744106B2 (en) 2020-08-18
EP3522884B1 (en) 2024-05-29
EP3522884C0 (en) 2024-05-29
US20230321022A1 (en) 2023-10-12
US20200352890A1 (en) 2020-11-12
CN109803648A (zh) 2019-05-24
WO2018067705A1 (en) 2018-04-12
CA3039376A1 (en) 2018-04-12
ES2982757T3 (es) 2024-10-17
EP3522884A1 (en) 2019-08-14
EP3522884A4 (en) 2020-05-27

Similar Documents

Publication Publication Date Title
US20210395184A1 (en) Vinyl substituted fatty acids
US20230321022A1 (en) Reversibly protected thiolated electrophilic fatty acids as prodrugs
JP2021183640A (ja) 活性化脂肪酸の治療有効量を使用する疾患の予防、処置および逆転
JP2015508065A (ja) 抗炎症薬としての脂肪酸
US20150183754A1 (en) Fatty acid inhibitors
JP6959246B2 (ja) 治療に有効な量のジカルボン酸化合物を使用した、病気の予防、治療及び治癒
US11491128B2 (en) Reversible nitroxide derivatives of nitroalkenes that mediate nitrosating and alkylating reactions

Legal Events

Date Code Title Description
RD02 Notification of acceptance of power of attorney

Free format text: JAPANESE INTERMEDIATE CODE: A7422

Effective date: 20200820

RD04 Notification of resignation of power of attorney

Free format text: JAPANESE INTERMEDIATE CODE: A7424

Effective date: 20200820

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A821

Effective date: 20200820

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20201001

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20201001

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20211027

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20220126

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20220323

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20220420

A02 Decision of refusal

Free format text: JAPANESE INTERMEDIATE CODE: A02

Effective date: 20220720